Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database

References

• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
   PubMed Web of Science ®Google Scholar
• KesslerRStahlEVogelmeierCPatient understanding, detection, and experience of COPD exacerbations: an observational, interview-based studyChest2006130113314216840393
   PubMed Web of Science ®Google Scholar
• PiquetJChavaillonJMDavidPMartinFBlanchonFRocheNHigh-risk patients following hospitalisation for an acute exacerbation of COPDEur Respir J201342494695523349446
   PubMed Web of Science ®Google Scholar
• SinganayagamASchembriSChalmersJDPredictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary diseaseAnn Am Thorac Soc2013102818923607835
   PubMedGoogle Scholar
• GunenHHacievliyagilSSKosarFFactors affecting survival of hospitalised patients with COPDEur Respir J200526223424116055870
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• HoogendoornMHoogenveenRTRutten-van MolkenMPVestboJFeenstraTLCase fatality of COPD exacerbations: a meta-analysis and statistical modelling approachEur Respir J201137350851520595157
   PubMed Web of Science ®Google Scholar
• ToyELGallagherKFStanleyELSwensenARDuhMSThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD20107321422820486821
   PubMedGoogle Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• BeehKMGlaabTStowasserSCharacterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialRespir Res20131411624168767
   PubMed Web of Science ®Google Scholar
• ForemanMGDeMeoDLHershCPReillyJJSilvermanEKClinical determinants of exacerbations in severe, early-onset COPDEur Respir J20073061124113017715170
   PubMed Web of Science ®Google Scholar
• MullerovaHShuklaAHawkinsAQuintJRisk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort studyBMJ Open2014412e006171
   PubMed Web of Science ®Google Scholar
• MenezesAMMontes de OcaMPerez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
   PubMed Web of Science ®Google Scholar
• HardinMSilvermanEKBarrRGThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
   PubMed Web of Science ®Google Scholar
• WelteTVogelmeierCPapiACOPD: early diagnosis and treatment to slow disease progressionInt J Clin Pract201569333634925363328
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• ChoiJKPaekDLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis2005583230242
   Google Scholar
• FukuchiYFernandezLKuoHPEfficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trialRespirology201116582583521539680
   PubMed Web of Science ®Google Scholar
• KimJLeeJHKimYAssociation between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort studyBMC Pulm Med2013135123927016
   PubMed Web of Science ®Google Scholar
• KimJRheeCKYooKHThe health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service dataInt J Chron Obstruct Pulmon Dis2013856156824277985
   PubMed Web of Science ®Google Scholar
• KimCYooKHRheeCKHealth care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in KoreaInt J Tuberc Lung Dis201418673774324903947
   PubMed Web of Science ®Google Scholar
• RheeCKYoonHKYooKHMedical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthmaCOPD201411216317024111662
   PubMedGoogle Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• MiravitllesMGuerreroTMayordomoCSanchez-AgudoLNicolauFSeguJLFactors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study GroupRespiration200067549550111070451
   PubMed Web of Science ®Google Scholar
• BahadoriKFitzGeraldJMRisk factors of hospitalization and readmission of patients with COPD exacerbation – systematic reviewInt J Chron Obstruct Pulmon Dis20072324125118229562
   PubMedGoogle Scholar
• MiravitllesMCalleMAlvarez-GutierrezFGobarttELopezFMartinAExacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary diseaseQual Life Res200615347148016547786
   PubMed Web of Science ®Google Scholar
• GadouryMASchwartzmanKRouleauMSelf-management reduces both short- and long-term hospitalisation in COPDEur Respir J200526585385716264046
   PubMed Web of Science ®Google Scholar
• MiravitllesMIzquierdoIHerrejonACOPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA studyRespir Med2011105574074721227672
   PubMed Web of Science ®Google Scholar
• Gruffydd-JonesKBrusselleGJonesRChanges in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world studyNPJ Prim Care Respir Med2016
   Web of Science ®Google Scholar